KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Finished Goods: 2013-2015

  • Bausch Health Companies' Finished Goods rose 18.82% to $843.0 million in Q2 2015 from the same period last year, while for Jun 2015 it was $843.0 million, marking a year-over-year increase of 18.82%. This contributed to the annual value of $665.3 million for FY2014, which is 1.37% up from last year.
  • As of Q2 2015, Bausch Health Companies' Finished Goods stood at $843.0 million, which was up 26.71% from $665.3 million recorded in Q4 2014.
  • In the past 5 years, Bausch Health Companies' Finished Goods ranged from a high of $843.0 million in Q2 2015 and a low of $656.3 million during Q4 2013.
  • Moreover, its 3-year median value for Finished Goods was $687.4 million (2014), whereas its average is $718.5 million.
  • Data for Bausch Health Companies' Finished Goods shows a peak YoY climbed of 18.82% (in 2015) over the last 5 years.
  • Bausch Health Companies' Finished Goods (Quarterly) stood at $656.3 million in 2013, then climbed by 1.37% to $665.3 million in 2014, then rose by 18.82% to $843.0 million in 2015.
  • Its last three reported values are $843.0 million in Q2 2015, $665.3 million for Q4 2014, and $709.5 million during Q2 2014.